The weekly litigation news digest is live. Subscribe now

IP Verse

Aptalis Pharma competitive analysis

Loading summary...

Latest patents of Aptalis Pharma opposed by its competitors

Explore Aptalis Pharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Dec 11, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP3024479
Feb 8, 2023High Potency Pancreatin Pharmaceutical Compositions1
EP3003360
Oct 7, 2020High Potency Pancreatin Pharmaceutical Compositions1
EP2646003
Jun 3, 2020Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods1
EP2477645
Aug 15, 2018Pancreatic Enzyme Compositions And Methods For Treating Pancreatitis And Pancreatic Insufficiency1
EP2482822
Aug 1, 2018Orally Administered Corticosteroid Compositions1
EP2818160
Nov 8, 2017Enteric Coated, Low-Strength Pancrelipase Formulations1

Latest PTAB cases involving Aptalis Pharma

Discover the latest PTAB cases involving Aptalis Pharma, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Aptalis Pharma with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Dec 11, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
APTALIS PHARMA - 4 - -
CAMULON14 - - -
MATHYS & SQUIRE54 - - -